Cyclin-dependent kinase inhibition reduces lung damage in a mouse model of ventilator-induced lung injury

Shock

Volumn 38, Issue 4, 2012, Pages 375-380

  Hoogendijk, Arie J ^a   Kuipers, Maria T ^a   Van Der Poll, Tom ^a   Schultz, Marcus J ^a   Wieland, Catharina W ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

apoptosis; mechanical ventilation; PMNs; pulmonary inflammation; Ventilator induced lung injury

Indexed keywords

CYCLIN DEPENDENT KINASE; IMMUNOGLOBULIN M; ROSCOVITINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; ENZYME INHIBITION; IN VITRO STUDY; LUNG LAVAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; TIDAL VOLUME; TRACHEOSTOMY; VENTILATOR INDUCED LUNG INJURY;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CELLS, CULTURED; CYCLIN-DEPENDENT KINASES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; LUNG; MALE; MICE; NEUTROPHILS; PROTEIN KINASE INHIBITORS; PURINES; RECEPTORS, IMMUNOLOGIC; VENTILATOR-INDUCED LUNG INJURY; VENTILATORS, MECHANICAL;

EID: 84866620163     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3182656e7b     Document Type: Article

References (36)

1. Putensen C, Theuerkauf N, Zinserling J, Wrigge H, Pelosi P: Meta-analysis: ventilation strategies and outcomes of the acute respiratory distress syndrome and acute lung injury. Ann Intern Med 151:566-576, 2009.
2. Schultz MJ, Haitsma JJ, Slutsky AS, Gajic O: What tidal volumes should be used in patients without acute lung injury? Anesthesiology 106:1226-1231, 2007.
3. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 342:1301-1308, 2000.
4. Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G, Kairalla RA, Deheinzelin D, Munoz C, Oliveira R, et al.: Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 338:347-354, 1998.
5. Ranieri VM, Suter PM, Tortorella C, De TR, Dayer JM, Brienza A, Bruno F, Slutsky AS: Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA 282:54-61, 1999.
6. Ranieri VM, Giunta F, Suter PM, Slutsky AS: Mechanical ventilation as a mediator of multisystem organ failure in acute respiratory distress syndrome. JAMA 284:43-44, 2000.
7. Oeckler RA, Hubmayr RD: Cell wounding and repair in ventilator injured lungs. Respir Physiol Neurobiol 163:44-53, 2008.
8. Gattinoni L, Pesenti A: The concept of Bbaby lung. Intensive Care Med 31: 776-784, 2005.
9. Bach S, Knockaert M, Reinhardt J, Lozach O, Schmitt S, Baratte B, Koken M, Coburn SP, Tang L, Jiang T, et al.: Roscovitine targets, protein kinases and pyridoxal kinase. J Biol Chem 280:31208-31219, 2005.
10. Knockaert M, Greengard P, Meijer L: Pharmacological inhibitors of cyclin-dependent kinases. Trends Pharmacol Sci 23:417-425, 2002.
11. Pippin JW, Qu Q, Meijer L, Shankland SJ: Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomeru-lonephritis with roscovitine, a novel cyclin-dependent kinase antagonist. J Clin Invest 100:2512-2520, 1997.
12. Alvi AJ, Austen B, Weston VJ, Fegan C, MacCallum D, Gianella-Borradori A, Lane DP, Hubank M, Powell JE, Wei W, et al.: A novel CDK inhibitor, CYC202 (r-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival. Blood 105:4484-4491, 2005.
13. Rossi AG, Sawatzky DA, Walker A, Ward C, Sheldrake TA, Riley NA, Caldicott A, Martinez-Losa M, Walker TR, Duffin R, et al.: Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat Med 12:1056-1064, 2006.
14. Goodyear S, Sharma MC: Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5. Exp Mol Pathol 82:25-32, 2007.
15. Koedel U, Frankenberg T, Kirschnek S, Obermaier B, Hacker H, Paul R, Hacker G: Apoptosis is essential for neutrophil functional shutdown and determines tissue damage in experimental pneumococcal meningitis. PLoS Pathog 5:e1000461, 2009.
16. Leitch AE, Riley NA, Sheldrake A, Festa M, Fox S, Duffin R, Haslett C, Rossi AG: The cyclin-dependent kinase inhibitor r-roscovitine down-regulates MCL-1 to override pro-inflammatory signalling and drive neutrophil apoptosis. Eur J Immunol 40:1127-1138, 2010.
17. Wolthuis EK, Vlaar AP, Choi G, Roelofs JJ, Juffermans NP, Schultz MJ: Mechanical ventilation using non-injurious ventilation settings causes lung injury in the absence of pre-existing lung injury in healthy mice. Crit Care 13:R1, 2009.
18. Uchida T, Shirasawa M, Ware LB, Kojima K, Hata Y, Makita K, Mednick G, Matthay ZA, Matthay MA: Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 173:1008-1015, 2006.
19. van der Windt GJ, Schouten M, Zeerleder S, Florquin S, van der Poll T: CD44 is protective during hyperoxia-induced lung injury. Am J Respir Cell Mol Biol 44:377-383, 2010.
20. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, Stelfox T, Bagshaw S, Choong K, Lamontagne F, et al.: Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 302:1872-1879, 2009.
21. Ramsey C, Fowler RA, Kumar A: Mechanical ventilation in critically ill patients with 2009 influenza A(H1N1) [reply]. JAMA 303:940-940, 2010.
22. van Zoelen MA, Ishizaka A, Wolthuls EK, Choi G, van der Poll T, Schultz MJ: Pulmonary levels of high-mobility group box 1 during mechanical ventilation and ventilator-associated pneumonia. Shock 29:441-445, 2008.
23. Uchida T, Shirasawa M, Ware LB, Kojima K, Hata Y, Makita K, Mednick G, Matthay ZA, Matthay MA: Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 173:1008-1015, 2006.
24. Newman V, Gonzalez RF, Matthay MA, Dobbs LG: A novel alveolar type I cell-specific biochemical marker of human acute lung injury. Am J Respir Crit Care Med 161:990-995, 2000.
25. Holter JF, Weiland JE, Pacht ER, Gadek JE, Davis WB: Protein permeability in the adult respiratory distress syndrome. Loss of size selectivity of the alveolar epithelium. J Clin Invest 78:1513-1522, 1986.
26. Slutsky AS: Lung injury caused by mechanical ventilation. Chest 116:9S-15S, 1999.
27. Determann RM, Royakkers A, Wolthuis EK, Vlaar AP, Choi G, Paulus F, Hofstra JJ, de Graaff MJ, Korevaar JC, Schultz MJ: Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: a preventive randomized controlled trial. Crit Care 14:R1, 2010.
28. Kawano T, Mori S, Cybulsky M, Burger R, Ballin A, Cutz E, Bryan AC: Effect of granulocyte depletion in a ventilated surfactant-depleted lung. J Appl Physiol 62:27-33, 1987.
29. Kotani M, Kotani T, Ishizaka A, Fujishima S, Koh H, Tasaka S, Sawafuji M, Ikeda E, Moriyama K, Kotake Y, et al.: Neutrophil depletion attenuates inter-leukin-8 production in mild-overstretch ventilated normal rabbit lung. Crit Care Med 32:514-519, 2004.
30. Jeyaseelan S, Young SK, Yamamoto M, Arndt PG, Akira S, Kolls JK, Worthen GS: Toll/IL-1R domain-containing adaptor protein (TIRAP) is a critical mediator of antibacterial defense in the lung against Klebsiella pneumoniae but not Pseudomonas aeruginosa. J Immunol 177:538-547, 2006.
31. Brown KA, Brain SD, Pearson JD, Edgeworth JD, Lewis SM, Treacher DF: DF: Neutrophils in development of multiple organ failure in sepsis. The Lancet 368:157-169, 2006.
32. Raje N, Kumar S, Hideshima T, Roccaro A, Ishitsuka K, Yasui H, Shiraishi N, Chauhan D, Munshi NC, Green SR, et al.: Seliciclib (CYC202 or r-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of MCL-1 in multiple myeloma. Blood 106:1042-1047, 2005.
33. Thomas LW, Lam C, Edwards SW: MCL-1; the molecular regulation of protein function. FEBS Lett 584:2981-2989, 2010.
34. Hallaert DY, Spijker R, Jak M, Derks IA, Alves NL, Wensveen FM, de Boer JP, de Jong D, Green SR, van Oers MH, et al.: Crosstalk among Bcl-2 family members in B-CLL: seliciclib acts via the MCL-1/Noxa axis and gradual exhaustion of Bcl-2 protection. Cell Death Differ 14:1958-1967, 2007.
35. Berberich N, Uhl B, Joore J, Schmerwitz UK, Mayer BA, Reichel CA, Krombach F, Zahler S, Vollmar AM, Furst R: Roscovitine blocks leukocyte extravasation by inhibition of cyclin-dependent kinases 5 and 9. Br J Pharmacol 163:1086-1098, 2011.
36. Benson C, White J, Bono JD, O'Donnell A, Raynaud F, Cruickshank C, McGrath H, Walton M, Workman P, Kaye S, et al.: A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; r-roscovitine), administered twice daily for 7 days every 21 days. Br J Cancer 96:29-37, 2007.